21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.38.Z - Wholesale trade of other food products
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | -2,3 | -397 |
EBITDA | 0,8 | -1,9 | -334,4 |
Short time liabilities | 0,1 | 2,2 | 2607,3 |
Equity capital | 5,7 | 3,4 | -40,5 |
Operating profit (EBIT) | 0,8 | -2,2 | -378,8 |
Assets | 6 | 8,1 | 35,5 |
Net profit (loss) | 0,7 | -2,3 | -427,2 |
Cash | 0,1 | 0,2 | 63,6 |
Liabilities and provisions for liabilities | 0,3 | 4,7 | 1569,2 |
Net income from sale | 0 | 1,3 | -∞ |
Working assets | 1,3 | 1,8 | 41,7 |
Depreciation | 0 | 0,3 | 575 |
% | % | p.p. | |
Profitability of capital | 12,4 | -68,1 | -80,5 |
Equity capital to total assets | 95,3 | 41,8 | -53,5 |
Gross profit margin | -174,1 | ||
EBITDA Margin | -144,3 | ||
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 610 | -2 147 483 038 |
Current financial liquidity indicator | 15.526077270507812 | 0.8125379085540771 | -14,7 |
Net dept to EBITDA | 0.12335716933012009 | -1.2198820114135742 | -1,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane